Diabetic nephropathy and proximal tubular damage

Journal of Renal Nutrition

Volumn 25, Issue 2, 2015, Pages 230-233

  Tang, Sydney C W ^a   Yiu, Wai Han ^a   Lin, Miao ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; TOLL LIKE RECEPTOR;

ANIMAL; COMPLICATION; DIABETIC NEPHROPATHY; HUMAN; INFLAMMATION; KALLIKREIN KININ SYSTEM; KIDNEY PROXIMAL TUBULE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; INFLAMMATION; KALLIKREIN-KININ SYSTEM; KIDNEY TUBULES, PROXIMAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RECEPTORS, PROTEINASE-ACTIVATED; TOLL-LIKE RECEPTORS;

EID: 84925120711     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2014.10.020     Document Type: Review

References (20)

1. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004, 65:116-128.
2. Tang S.C., Lai K.N. The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol Dial Transplant 2012, 27:3049-3056.
3. Tang S.C., Leung J.C., Lai K.N. Diabetic tubulopathy: an emerging entity. Contrib Nephrol 2011, 170:124-134.
4. Tang S.C., Leung J.C., Chan L.Y., Tsang A.W., Lai K.N. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-{gamma} agonist. J Am Soc Nephrol 2006, 17:1633-1643.
5. Tang S.C., Leung J.C., Chan L.Y., Cheng A.S., Lan H.Y., Lai K.N. Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: role of STAT1 inhibition and nephrin restoration. Am J Nephrol 2010, 32:145-155.
6. Qi W., Holian J., Tan C.Y., Kelly D.J., Chen X.M., Pollock C.A. The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-gamma in the regulation of macrophage inflammatory protein-3alpha at early onset of diabetes. Int J Biochem Cell Biol 2010, 43:383-392.
7. Home P.D., Pocock S.J., Beck-Nielsen H., et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009, 373:2125-2135.
8. Saad S., Zhang J., Yong R., et al. Role of the EGF receptor in PPARgamma-mediated sodium and water transport in human proximal tubule cells. Diabetologia 2013, 56:1174-1182.
9. Tang S.C., Chan L.Y., Leung J.C., et al. Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant 2010, 25:698-710.
10. Tang S.C., Chan L.Y., Leung J.C., Cheng A.S., Lan H.Y., Lai K.N. Additive renoprotective effects of B2-kinin receptor blocker and PPAR-gamma agonist in uninephrectomized db/db mice. Lab Invest 2011, 91:1351-1362.
11. Tan Y., Keum J.S., Wang B., McHenry M.B., Lipsitz S.R., Jaffa A.A. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. Am J Physiol Renal Physiol 2007, 293:F1026-F1035.
12. Buleon M., Allard J., Jaafar A., et al. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol 2008, 294:F1249-F1256.
13. Kakoki M., Takahashi N., Jennette J.C., Smithies O. Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A 2004, 101:13302-13305.
14. Oikonomopoulou K., Hansen K.K., Saifeddine M., et al. Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem 2006, 281:32095-32112.
15. Yiu W.H., Wong D.W., Chan L.Y., et al. Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells. PLoS One 2014, 9:e88894.
16. Lin M., Yiu W.H., Wu H.J., et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012, 23:86-102.
17. Lin M., Yiu W.H., Li R.X., et al. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int 2013, 83:887-900.
18. Li F., Yang N., Zhang L., et al. Increased expression of toll-like receptor 2 in rat diabetic nephropathy. Am J Nephrol 2010, 32:179-186.
19. Mudaliar H., Pollock C., Komala M.G., Chadban S., Wu H., Panchapakesan U. The role of toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 2013, 305:F143-F154.
20. Lin M., Tang S.C. Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Nephrol Dial Transplant 2014, 29:746-754.